m+Medelevator.RU
← Поиск публикаций
Microbial pathogenesis · 2025

Lipopeptide: Exploration for enhanced anticandidal therapeutic spectrum.

СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Singh Vivek Kumar, Kumar Awanish

Аннотация

Growing numbers of human fungal contagions pose a significant threat to the health of society, which is largely brought on by an increase in the number of immunocompromised patients. Pathogenic fungi are usually ignored in discussions of human disease, though they create a big problem after infection. Immunocompromised patients have a high fatality rate due to severe invasive infections from a common polymorphic pathogenic fungus, Candida albicans. Treatment becomes more challenging when C. albicans builds biofilms in the body and on medical implants because they protect themselves from the human defense system and resist traditional antifungal medications. Quorum sensing in biofilm helps to develop drug resistance because it regulates gene expression and other biofilm-related activities. Available antifungal drugs now are not very effective against biofilm and are becoming more resistant. New antifungal choices are desperately needed, and they should contain unique biocompatible modes of action. Lipopeptides, a naturally occurring peptide group, have been shown as a promising antifungal substitute. They could be an effective, futuristic antifungal agent that stops the growth of pathogenic fungi in humans. Lipopeptides produced by bacteria, especially from Bacillus and Pseudomonas, are very powerful against pathogenic fungi. Cyclic lipopeptides such as surfactin, fengycin, iturins, and daptomycin damage Candida species' cell membranes because they are hydrophobic, prevent biofilm development, and could be efficacious antifungal agents. This review explores structural diversity, biosynthesis, and interactions of lipopeptides against C. albicans virulence factors. New treatment regimens for human fungal infections can be developed by recognizing and researching lipopeptides in-depth, urgently needed to develop potent, safe, and enhanced spectral antifungal arsenals in the future because there is now an insufficiency of effective antifungal medicine.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты